Toshiba 2015 Annual Report Download - page 23

Download and view the complete annual report

Please find page 23 of the 2015 Toshiba annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 70

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70

6%
Healthcare Technology Center in Kawasaki City
Sales by Segment Sales/Operating Income
200.0
400.0
500.0
10.0
20.0
30.0
40.0
50.0
100.0
0.0 0.0
300.0 29.9
412.5
23.9
FY13 FY14FY12
379.6
20.9
410.7
(Billions of yen)(Billions of yen)Sales Operating Income
Business Overview
DNA testing system Genelyzer™
Diagnostic X-ray systems, Computerized tomography (CT) systems, MRI systems,
Diagnostic ultrasound systems, Clinical analysis systems
Main products
& services
5%
9,601
Number of Employees by Segment
Healthcare Systems & Services
Opening Healthcare Technology Center
Efforts for DNA testing system
business
In December 2014, Toshiba opened the Healthcare
Technology Center. At this center, Toshiba will accelerate
creation of new products and services using genomic
analysis and biological sensors and also promote
development of the next-generation products through
collaboration with outside research institutes for diagnostic
imaging systems such as MRI and ultrasound systems for
which growth is expected. Presently, in the healthcare
systems & services business, increases in R&D cost and the
number of researchers are globally planned. In the future,
the business will be enhanced, centering on the following
areas: "diagnosis and treatment;" "prevention;" "prognosis
and nursing care;" and "health promotion."
As a specic approach toward the new area, Toshiba launched
GenelyzerTMII, a platform that makes DNA detection and
analysis automatically and Test Kits for Food Allergens to be set
on this platform. With this combination, time required for test
and determination can be largely reduced from some days to
about two hours. The Company plans to contribute to secure
and reliable food through spreading the system in food and
restaurant industries, etc., and launch a variety kind of kits
which can be applied in medical and other various areas.
Net sales in the Healthcare Systems & Services segment increased by ¥1.8 billion to ¥412.5 billion (US$3,437.6 million). While
sales of medical imaging systems were solid in North America and emerging economies, especially of mainstay CT systems, sales
in Japan were lower, aected by a revision of the medical fee reimbursement system and other factors.
Segment operating income decreased by ¥6.0 billion to ¥23.9 billion (US$198.9 million), reflecting continued up-front
investments made to drive forward future growth, particularly in R&D of next-generation CT systems.
Business Overview / Healthcare Systems & ServicesBusiness Overview / Community Solutions
22
TOSHIBA Annual Report 2015